Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Nalini Bora

Concepts (240)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uveitis, Anterior
10
2019
28
3.330
Why?
Autoimmune Diseases
11
2019
100
3.290
Why?
Choroidal Neovascularization
17
2022
54
3.250
Why?
Complement System Proteins
7
2014
46
1.970
Why?
Macular Degeneration
10
2016
47
1.940
Why?
Disease Models, Animal
22
2022
1451
1.830
Why?
Autoantigens
5
2009
58
1.290
Why?
Complement Activation
8
2010
42
1.270
Why?
Uveitis
5
2009
26
1.100
Why?
Rats, Inbred Lew
13
2019
69
1.090
Why?
Immune Tolerance
6
2009
95
1.070
Why?
Animals
41
2022
13150
0.920
Why?
Transforming Growth Factor beta2
5
2019
17
0.880
Why?
Rats
16
2019
3300
0.780
Why?
Choroid
5
2012
22
0.720
Why?
Geographic Atrophy
2
2016
7
0.670
Why?
Complement Factor B
2
2011
10
0.660
Why?
Complement Pathway, Alternative
2
2011
9
0.660
Why?
Antigens, Surface
3
2010
54
0.650
Why?
T-Lymphocytes, Regulatory
2
2009
85
0.650
Why?
Eye Diseases
3
2008
36
0.650
Why?
Recombinant Proteins
4
2019
486
0.620
Why?
CD4-Positive T-Lymphocytes
2
2011
163
0.610
Why?
Adiponectin
6
2022
64
0.610
Why?
Complement Membrane Attack Complex
6
2011
19
0.580
Why?
Eye
4
2006
31
0.580
Why?
Collagen Type I
2
2009
89
0.560
Why?
Antigens, Neoplasm
2
2008
151
0.500
Why?
Reverse Transcriptase Polymerase Chain Reaction
8
2014
595
0.500
Why?
Neovascularization, Pathologic
3
2012
161
0.480
Why?
Lasers
8
2011
119
0.480
Why?
Ethanol
3
2008
338
0.480
Why?
Blotting, Western
6
2016
602
0.460
Why?
Complement C4
2
2011
9
0.450
Why?
Interleukin-2 Receptor alpha Subunit
2
2009
9
0.430
Why?
Male
25
2020
25093
0.420
Why?
Mice
16
2022
5720
0.420
Why?
Receptors, Cell Surface
2
2010
121
0.410
Why?
Honey
1
2011
8
0.400
Why?
Keratitis
1
2011
11
0.390
Why?
Adoptive Transfer
5
2011
39
0.390
Why?
Pseudomonas Infections
1
2011
48
0.390
Why?
Eye Injuries
1
2011
26
0.380
Why?
Eye Infections, Bacterial
1
2011
29
0.380
Why?
Wound Healing
2
2016
206
0.380
Why?
Vascular Endothelial Growth Factor A
8
2016
201
0.380
Why?
Models, Biological
1
2014
728
0.380
Why?
Down-Regulation
3
2007
349
0.380
Why?
Complement C3
4
2014
24
0.370
Why?
Mice, Inbred C57BL
11
2020
1806
0.370
Why?
Complement Factor H
2
2010
10
0.370
Why?
Cell Proliferation
6
2020
1007
0.370
Why?
Protein Processing, Post-Translational
2
2009
171
0.370
Why?
Apoptosis
5
2014
1100
0.360
Why?
Enzyme-Linked Immunosorbent Assay
5
2016
245
0.360
Why?
Mice, Knockout
5
2016
841
0.340
Why?
Epitopes
1
2009
59
0.340
Why?
Complement Inactivator Proteins
2
2006
5
0.340
Why?
Immunohistochemistry
5
2014
971
0.320
Why?
Wet Macular Degeneration
2
2022
12
0.310
Why?
Cattle
4
2009
210
0.310
Why?
Acyltransferases
2
2006
29
0.300
Why?
Complement C3b
2
2006
7
0.290
Why?
Retinal Pigment Epithelium
3
2016
18
0.280
Why?
Esters
1
2006
22
0.270
Why?
Immunity, Innate
1
2007
104
0.270
Why?
Fatty Acids
1
2006
143
0.260
Why?
Angiogenesis Inhibitors
2
2020
187
0.260
Why?
Lipoxygenase Inhibitors
1
2005
6
0.260
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
26
0.250
Why?
Cyclooxygenase Inhibitors
1
2005
39
0.250
Why?
Nitric Oxide Synthase
1
2005
75
0.250
Why?
Antigens, CD
2
2003
215
0.250
Why?
Immunologic Factors
1
2006
114
0.250
Why?
Carboxylic Ester Hydrolases
1
2003
7
0.230
Why?
Injections, Intravenous
3
2009
140
0.230
Why?
Mutagenesis, Site-Directed
1
2003
99
0.230
Why?
Avian Proteins
1
2003
4
0.220
Why?
Antigen-Presenting Cells
1
2003
26
0.220
Why?
Blood Proteins
1
2003
82
0.210
Why?
Polyethylene Glycols
2
2014
96
0.210
Why?
Cytokines
3
2011
612
0.200
Why?
Injections, Intraocular
2
2019
6
0.200
Why?
Myocardium
1
2003
429
0.190
Why?
Trabeculectomy
1
2020
8
0.190
Why?
Trityl Compounds
1
2020
2
0.190
Why?
Butyric Acid
1
2020
10
0.190
Why?
Acetamides
1
2020
20
0.180
Why?
Glaucoma
1
2020
30
0.180
Why?
Transforming Growth Factor beta
3
2006
144
0.170
Why?
Peptide Fragments
2
2012
216
0.170
Why?
Endotoxins
2
2011
34
0.170
Why?
Nicotine
2
2012
186
0.170
Why?
Melanins
2
2011
27
0.160
Why?
Specific Pathogen-Free Organisms
2
2009
18
0.160
Why?
Immunoglobulin G
2
2011
186
0.160
Why?
Thalidomide
1
2020
374
0.160
Why?
RNA, Small Interfering
3
2010
215
0.150
Why?
Pigment Epithelium of Eye
2
2010
8
0.150
Why?
Humans
16
2022
49827
0.150
Why?
Lymph Nodes
2
2009
264
0.140
Why?
Gene Expression Regulation
3
2014
979
0.140
Why?
T-Lymphocytes
1
2019
338
0.140
Why?
Retinal Degeneration
1
2016
11
0.140
Why?
Alcohol Drinking
2
2008
223
0.130
Why?
Chemokine CCL2
2
2016
71
0.130
Why?
RNA, Messenger
3
2010
1105
0.130
Why?
Amino Acid Sequence
3
2009
587
0.130
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2016
121
0.120
Why?
Aspirin
1
2016
114
0.120
Why?
Photoreceptor Cells, Vertebrate
1
2014
3
0.120
Why?
Peptides
2
2022
222
0.120
Why?
Follow-Up Studies
2
2011
2179
0.110
Why?
In Situ Nick-End Labeling
2
2014
57
0.110
Why?
Vascular Endothelial Growth Factors
1
2012
15
0.110
Why?
Molecular Sequence Data
2
2004
797
0.100
Why?
Receptors, Adiponectin
3
2022
10
0.100
Why?
Membrane Glycoproteins
2
2003
240
0.100
Why?
Proliferating Cell Nuclear Antigen
3
2022
75
0.100
Why?
Administration, Topical
1
2011
54
0.100
Why?
Cornea
1
2011
51
0.100
Why?
Pseudomonas aeruginosa
1
2011
72
0.100
Why?
Lipoproteins, LDL
1
2012
170
0.100
Why?
Endothelium, Vascular
1
2012
254
0.090
Why?
Drug Carriers
1
2011
68
0.090
Why?
Fluorescent Antibody Technique
1
2010
108
0.090
Why?
Antibodies, Monoclonal, Humanized
1
2012
222
0.090
Why?
RNA
1
2011
170
0.090
Why?
Autoantibodies
1
2011
116
0.090
Why?
Microscopy, Confocal
3
2005
87
0.090
Why?
Lymphocyte Depletion
1
2009
8
0.090
Why?
Immunization
1
2009
67
0.090
Why?
Cell Membrane
1
2010
248
0.080
Why?
Forkhead Transcription Factors
1
2009
112
0.080
Why?
Lymphocyte Count
1
2008
21
0.080
Why?
Interleukin-2
1
2008
72
0.080
Why?
Coculture Techniques
1
2008
146
0.080
Why?
Treatment Outcome
2
2011
5138
0.080
Why?
Caspase 8
1
2007
12
0.080
Why?
Caspase 9
1
2007
15
0.080
Why?
Cell Line
3
2020
1002
0.080
Why?
Cytochromes c
1
2007
29
0.080
Why?
Diet
2
2016
564
0.080
Why?
bcl-2-Associated X Protein
1
2007
56
0.070
Why?
Caspase 3
1
2007
97
0.070
Why?
Growth Substances
1
2007
23
0.070
Why?
Anterior Chamber
1
2007
8
0.070
Why?
Proto-Oncogene Proteins c-bcl-2
1
2007
129
0.070
Why?
Complement C5
1
2006
3
0.070
Why?
Complement C1q
1
2006
9
0.070
Why?
Receptors, Complement
1
2006
3
0.070
Why?
Complement C3-C5 Convertases
1
2006
3
0.070
Why?
Oligodeoxyribonucleotides, Antisense
1
2006
4
0.070
Why?
Antibodies, Blocking
1
2006
8
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2007
104
0.070
Why?
Cyclin E
1
2006
6
0.070
Why?
Cyclin-Dependent Kinase 2
1
2006
16
0.070
Why?
Macrophage-1 Antigen
1
2006
9
0.070
Why?
Fluorescent Antibody Technique, Indirect
1
2006
21
0.070
Why?
Recombinant Fusion Proteins
1
2007
182
0.070
Why?
Inflammation
1
2010
604
0.070
Why?
Models, Molecular
1
2007
337
0.070
Why?
Chemokines
1
2006
77
0.070
Why?
Risk Factors
1
2014
3619
0.070
Why?
Cell Adhesion Molecules
1
2006
85
0.070
Why?
Arachidonate 5-Lipoxygenase
1
2005
4
0.060
Why?
Collagen
1
2007
206
0.060
Why?
Cyclooxygenase 2 Inhibitors
1
2005
19
0.060
Why?
Injections, Subcutaneous
1
2005
52
0.060
Why?
Guanidines
1
2005
31
0.060
Why?
Nitric Oxide Synthase Type II
1
2005
66
0.060
Why?
Cyclooxygenase 2
1
2005
45
0.060
Why?
Flow Cytometry
1
2007
470
0.060
Why?
Macrophages
1
2007
364
0.060
Why?
Fibroblast Growth Factors
1
2005
47
0.060
Why?
Up-Regulation
1
2006
450
0.060
Why?
Immune Sera
1
2004
17
0.060
Why?
Pyrazoles
1
2005
113
0.060
Why?
Organ Specificity
1
2004
108
0.060
Why?
Sequence Homology
1
2003
20
0.060
Why?
COS Cells
1
2003
75
0.060
Why?
Sulfonamides
1
2005
129
0.060
Why?
Bruch Membrane
1
2003
1
0.060
Why?
Enzyme Activation
1
2003
276
0.060
Why?
Hypersensitivity, Delayed
1
2003
21
0.050
Why?
Disease Progression
1
2006
822
0.050
Why?
Interleukin-12
1
2003
31
0.050
Why?
Fluorescein-5-isothiocyanate
1
2022
7
0.050
Why?
Ophthalmic Solutions
1
2022
18
0.050
Why?
Interleukin-10
1
2003
84
0.050
Why?
Structure-Activity Relationship
1
2003
394
0.050
Why?
Antibodies, Monoclonal
1
2006
458
0.050
Why?
Cells, Cultured
3
2012
1571
0.050
Why?
Antibodies, Neutralizing
2
2012
64
0.050
Why?
Time Factors
3
2014
2912
0.050
Why?
Tetrazolium Salts
1
2020
13
0.050
Why?
Rats, Inbred BN
2
2012
17
0.050
Why?
Immunotherapy
1
2003
238
0.050
Why?
Mitomycin
1
2020
19
0.050
Why?
Lidocaine
1
2020
49
0.050
Why?
Human Umbilical Vein Endothelial Cells
1
2020
90
0.040
Why?
Aging
1
2004
688
0.040
Why?
Endothelial Cells
2
2012
269
0.040
Why?
Mutation
1
2003
1293
0.040
Why?
Immunoenzyme Techniques
2
2010
143
0.040
Why?
Female
1
2016
26329
0.030
Why?
Complement C1 Inhibitor Protein
1
2014
3
0.030
Why?
Aminopeptidases
1
2014
17
0.030
Why?
Matrix Metalloproteinase 9
1
2014
86
0.030
Why?
Serine Endopeptidases
1
2014
52
0.030
Why?
Autophagy
1
2014
168
0.030
Why?
Bungarotoxins
1
2012
6
0.030
Why?
Intravitreal Injections
1
2012
35
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
32
0.030
Why?
Aged
2
2022
9272
0.030
Why?
Receptors, Nicotinic
1
2012
76
0.030
Why?
Oxidation-Reduction
1
2012
319
0.020
Why?
Complement C9
1
2011
3
0.020
Why?
Polymerase Chain Reaction
1
2012
455
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2012
412
0.020
Why?
Analysis of Variance
1
2012
565
0.020
Why?
Dose-Response Relationship, Drug
1
2014
1374
0.020
Why?
Vision, Ocular
1
2010
11
0.020
Why?
Transcriptome
1
2012
313
0.020
Why?
Gene Expression
1
2012
608
0.020
Why?
Protein Structure, Tertiary
1
2009
253
0.020
Why?
Models, Animal
1
2009
233
0.020
Why?
Immune System
1
2004
44
0.020
Why?
Immunoblotting
1
2003
118
0.010
Why?
Thromboplastin
1
2003
6
0.010
Why?
Gene Library
1
2003
44
0.010
Why?
Cell Adhesion
1
2003
158
0.010
Why?
Adenoviridae
1
2003
51
0.010
Why?
DNA, Complementary
1
2003
135
0.010
Why?
Genetic Vectors
1
2003
127
0.010
Why?
Retina
1
2003
63
0.010
Why?
Swine
1
2003
391
0.010
Why?
Protein Binding
1
2003
660
0.010
Why?
Liver
1
2003
1109
0.010
Why?
Middle Aged
1
2003
11997
0.000
Why?
Bora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description